(Q40007933)

English

Roles of osteoclasts and bone-derived IGFs in the survival and growth of human breast cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Roles of osteoclasts and bone-derived IGFs in the survival and growth of human breast cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

10

object named as

Atsushi Ochiai

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Genichiro Ishii

6

object named as

Genichiro Ishii

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

7

object named as

Kanji Nagai

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Takafumi Sangai

1

object named as

Takafumi Sangai

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hiroshi Fujimoto

2

object named as

Hiroshi Fujimoto

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Shin'ichi Miyamoto

3

object named as

Shin'ichi Miyamoto

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Masaru Miyazaki

9

object named as

Masaru Miyazaki

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Hiroyuki Maeda

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Michio Nakamura

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Takeshi Nagashima

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

29 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Clinical & Experimental Metastasis

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

401-410

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

https://scigraph.springernature.com/pub.10.1007/s10585-008-9144-8

0 references

Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG).

1 reference

https://api.crossref.org/works/10.1007%2FS10585-008-9144-8

21 January 2018

Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of structural domains of human osteoclastogenesis inhibitory factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone metastases: pathophysiology and management policy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kallikrein 11 expressed in human breast cancer cells releases insulin-like growth factor through degradation of IGFBP-3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer: bisphosphonate therapy for metastatic bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The distribution of secondary growths in cancer of the breast. 1889

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toward new horizons: the future of bisphosphonate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting of therapeutic agents to bone to treat metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RANK ligand is a prerequisite for cancer-associated osteolytic lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10585-008-9144-8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40007933&oldid=1882330244"